Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LEXICON PHARMACEUTICALS, INC. | Director | Common Stock | 48.4K | $127K | $2.62 | Apr 28, 2024 | Direct |
LEXICON PHARMACEUTICALS, INC. | Director | Restricted Stock Units | 36.8K | $96.4K | $2.62 | May 13, 2024 | Direct |
LEXICON PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 44.9K | May 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LXRX | LEXICON PHARMACEUTICALS, INC. | May 13, 2024 | 2 | $0 | 4 | May 13, 2024 | Director |
LXRX | LEXICON PHARMACEUTICALS, INC. | Apr 28, 2024 | 2 | $0 | 4 | Apr 29, 2024 | Director |
LXRX | LEXICON PHARMACEUTICALS, INC. | May 21, 2023 | 2 | $0 | 4 | May 22, 2023 | Director |
LXRX | LEXICON PHARMACEUTICALS, INC. | Apr 28, 2023 | 2 | $0 | 4 | Apr 28, 2023 | Director |
LXRX | LEXICON PHARMACEUTICALS, INC. | May 21, 2022 | 2 | $0 | 4 | May 23, 2022 | Director |
LXRX | LEXICON PHARMACEUTICALS, INC. | Apr 30, 2022 | 2 | $0 | 4 | May 2, 2022 | Director |